Skip to main content

Table 4 Analysis of primary outcome

From: Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan

Time point

SZF, number, mean (SD)

Irbesartan, number, mean (SD)

Mean difference (95% CI)

p value

Visit at

n = xx

n = xx

  

Week 0

xx (xx)

xx (xx)

xx (xx to xx)

.xx

Week 4 a

xx (xx)

xx (xx)

xx (xx to xx)

.xx

Week 8

xx (xx)

xx (xx)

xx (xx to xx)

.xx

Week 12

xx (xx)

xx (xx)

xx (xx to xx)

.xx

Week 16

xx (xx)

xx (xx)

xx (xx to xx)

.xx

Week 20

xx (xx)

xx (xx)

xx (xx to xx)

.xx

Week 24

xx (xx)

xx (xx)

xx (xx to xx)

.xx

Overall SZF effectb

   

.xx

  1. a,bp values comparing between group differences at visit points post-randomization (a) and over the entire24-week trial (b: primary outcome)
Back to article page

Trials

ISSN: 1745-6215